SecBot SecBot
SECBOTREPLAY Home › Report › ANIP

ANIP · Multiple executives at ANI Pharmaceuticals, including the CEO, CFO, and…

ANI PHARMACEUTICALS INC · CLUSTER filed Mar 3, 2026 at 18:01 ET

At the news

NEUTRALIMPACT 5/10

CLUSTER filed Mar 3, 2026 at 18:01 ET

Multiple executives at ANI Pharmaceuticals, including the CEO, CFO, and other senior leaders, engaged in tax-related share withholdings and open-market sales over the past week. The total value of transactions exceeds $2.6 million, with $913,092 in open-market sales and $1.7 million in tax withholding dispositions.

  • CEO Nikhil Lalwani surrendered 17,060 shares ($1.26M) for tax withholding.
  • CFO Stephen Carey and other SVPs also surrendered shares for tax purposes, totaling $1.7M across four executives.
  • Two executives, Christopher Mutz and Krista Davis, conducted open-market sales totaling $913,092.
  • All open-market sales occurred at prices between $74.13 and $75.00.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access